Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Mayo Clin Proc ; 90(5): 606-12, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25863416

RESUMO

OBJECTIVE: To determine the incidence of ventricular tachycardia and ventricular fibrillation in patients with prolonged corrected QT interval (QTc) who received levofloxacin through retrospective chart review at a tertiary care teaching hospital in the United States. PATIENTS AND METHODS: We selected 1004 consecutive hospitalized patients with prolonged QTc (>450 ms) between October 9, 2009 and June 12, 2012 at our institution. Levofloxacin was administered orally and/or intravenously and adjusted to renal function in the inpatient setting. The primary outcome measure was sustained ventricular tachycardia recorded electrocardiographically. RESULTS: With a median time from the start of levofloxacin use to hospital discharge (or death) of 4 days (range, 1-94 days), only 2 patients (0.2%; 95% CI, 0.0%-0.7%) experienced the primary outcome of sustained ventricular tachycardia after the initiation of levofloxacin use. CONCLUSION: In this study, the short-term risk for sustained ventricular tachycardia in patients with a prolonged QTc who subsequently received levofloxacin was very rare. These results suggest that levofloxacin may be a safe option in patients with prolonged QTc; however, studies with longer follow-up are needed.


Assuntos
Antibacterianos/efeitos adversos , Levofloxacino/efeitos adversos , Síndrome do QT Longo/complicações , Taquicardia Ventricular/induzido quimicamente , Taquicardia Ventricular/epidemiologia , Torsades de Pointes/induzido quimicamente , Torsades de Pointes/epidemiologia , Idoso , Feminino , Hospitalização , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
2.
J Healthc Inf Manag ; 19(3): 65-70, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16045086

RESUMO

Medical research relies on access to clinical data. Health Insurance Portability and Accountability Act regulations require that patient information required for clinical research not have data that can be used to identify the patients from whose medical records the information has been derived. The only exception would be an institutional review board (IRB)-approved study for which the researcher has obtained a waiver to use patient data for a research study. Before requesting an IRB waiver, however, the researcher may want to search the clinical data for particular characteristics or determine whether the quantity of data warrant obtaining IRB approval. The application, the Simple PAtient Note Scrubber, or SPANS, reviews and changes line content through an iterative process. At each iteration, SPANS analyzes changes made during the previous pass and reviews changes in relation to terms adjacent to the newly altered data. Knowledge of the document domain, encompassing the different types of documents to be scrubbed, is the key to making this type of process effective.


Assuntos
Algoritmos , Pesquisa Biomédica , Armazenamento e Recuperação da Informação , Sistemas Computadorizados de Registros Médicos , Sistemas de Identificação de Pacientes , Acesso à Informação/legislação & jurisprudência , Confidencialidade/legislação & jurisprudência , Health Insurance Portability and Accountability Act , Humanos , Unified Medical Language System , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA